Clinical Trial

The Puerto Rico Asthma Integrated Response Program ("PR-AIR")

Study acronym: PR-AIR
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to adapt and deliver an evidence-based multi-level intervention to reduce asthma disparities, and that promote and improve population health in the high-burden communities of San Juan, Puerto Rico. The Puerto Rico-Asthma Integrated Response Program (PR-AIR) will be implemented and evaluated to address pediatric asthma disparities in San Juan, PR, an area of high asthma burden. This study unfolds in two phases: In Phase 1, the researchers will collaborate with community stakeholders to identify needs, barriers and facilitators of PR-AIR implementation. Phase 2 consists of an evaluation of low-intensity (virtual) and high-intensity (in-person) methods of PR-AIR implementation outcomes using the RE-AIM (Reach, Effectiveness, Adoption, Implementation, and Maintenance) framework and a mixed methods approach.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2023-08-11; most recent amendment 2025-08-14.
Status change: Not Yet Recruiting → Recruiting 2025-04-03
Trial Details
NCT Number NCT05999032
Lead Sponsor Rhode Island Hospital
Collaborators: University of Puerto Rico
Conditions Pediatric Asthma
Enrollment 480 participants
Start Date 2024-12-16
Primary Completion 2026-11-30 (estimated)
Study Completion 2027-07-31 (estimated)
Updated on ClinicalTrials.gov 2025-08-20